March 8, 2022
Life Sciences
  • Moderna Inc. suggested it is ready to enforce its COVID-19 vaccine patents in wealthier countries, but didn’t specify a timeline. According to CEO Stéphane Bancel, Moderna is open to licensing its patents in higher-income nations on “commercially reasonable terms.” The company said it will not use its patents to block the shot’s production in more than 90 lower-income countries. (Articles here and here)